St. Charles Cancer Center is a clinical research site located in Bend, Oregon, United States 97701.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
St. Charles Cancer Center has participated in 2 clinical trials.
Therapeutic areas: Tumor Pathway Activations Inhibited by Dovitinib, Solid Tumor and Hematologic Malignancies.
Sponsors: Novartis Pharmaceuticals, Pfizer.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
St. Charles Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
St. Charles Cancer Center has 2 clinical trials on record. Their work covers Tumor Pathway Activations Inhibited by Dovitinib, Solid Tumor and Hematologic Malignancies.
St. Charles Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.